Health experts in Hong Kong say the government may need to reconsider its plan to buy the Astrazeneca vaccine, due to concerns over its efficacy.
They say authorities should focus on further rollout of the BioNTech jab instead, due to its effectiveness against COVID-19 variants.
Richard Kimber reports from Hong Kong.
IN: Hong Kong's health authorities
OUT: Richard Kimber, Hong Kong
DUR: 0.50